|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-9-22
|
|
pubmed:abstractText |
The therapeutic strategies of applying adefovir for treating lamivudine resistant HBV mutants are controversial. Thus, we observed the clinical outcomes after discontinuation of lamivudine to establish the timing to initiate adefovir therapy.
|
|
pubmed:language |
kor
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1738-222X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
227-42
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16177549-Adenine,
pubmed-meshheading:16177549-Adult,
pubmed-meshheading:16177549-Antiviral Agents,
pubmed-meshheading:16177549-Drug Resistance, Viral,
pubmed-meshheading:16177549-Female,
pubmed-meshheading:16177549-Hepatitis B, Chronic,
pubmed-meshheading:16177549-Hepatitis B e Antigens,
pubmed-meshheading:16177549-Hepatitis B virus,
pubmed-meshheading:16177549-Humans,
pubmed-meshheading:16177549-Lamivudine,
pubmed-meshheading:16177549-Male,
pubmed-meshheading:16177549-Middle Aged,
pubmed-meshheading:16177549-Phosphonic Acids,
pubmed-meshheading:16177549-Reverse Transcriptase Inhibitors,
pubmed-meshheading:16177549-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
[Clinical outcomes after discontinuation of Lamivudine in chronic hepatitis B patients with Lamivudine resistant HBV mutant].
|
|
pubmed:affiliation |
Department of Internal Medicine, College of Medicine, Pochon CHA University, Sungnam, Korea.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
